Skip to content

Individualized Neurodevelopmental Treatment

Individualized Neurodevelopmental Treatment

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00922077
Enrollment
1
Registered
2009-06-17
Start date
2008-01-31
Completion date
2008-04-30
Last updated
2009-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Brief summary

The purpose of the study was to evaluate this therapeutic intervention by expressing functional level with valid quantitative data.

Detailed description

The intervention lasted 6 weeks. There were 3 sessions per week. At each session there was a part of standard physical therapy program and there was also a part with emphasis on dynamic balance exercises.

Interventions

BEHAVIORALstandard physical therapy program with emphasis on dynamic balance exercises

Sponsors

Hellenic Society for Disabled Children
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Eligibility

Sex/Gender
FEMALE
Age
6 Years to 9 Years

Inclusion criteria

* spastic tetraplegia

Exclusion criteria

* vision problems

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026